Snibe Diagnostic (India) Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 5.00 Cr
as on 03-07-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 10.91%
(FY 2023)
- Profit -42.01%
(FY 2023)
- Ebitda -41.45%
(FY 2023)
- Net Worth 55.48%
(FY 2023)
- Total Assets 94.17%
(FY 2023)
About Snibe Diagnostic (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Snibe Diagnostic (India) Private Limited India is Srikanta Pati as COMPANY SECRETARY. Anand Kushwaha, Haiyan Liu, and Lei Zhang serve as directors at the Company.
- CIN/LLPIN
U74999HR2018FTC075069
- Company No.
075069
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
20 Jul 2018
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Snibe Diagnostic (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srikanta Pati  | Company Secretary | 01-Dec-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Kushwaha | Director | 20-Oct-2018 | Current |
Haiyan Liu  | Director | 20-Jul-2018 | Current |
| Lei Zhang | Director | 20-Jul-2018 | Current |
Financial Performance of Snibe Diagnostic (India).
Snibe Diagnostic (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.91% increase. The company also saw a substantial fall in profitability, with a 42.01% decrease in profit. The company's net worth Soared by an impressive increase of 55.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Snibe Diagnostic (India)?
In 2023, Snibe Diagnostic (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Snibe Diagnostic (India)?
Snibe Diagnostic (India) has a workforce of 19 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Snibe Diagnostic (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snibe Diagnostic (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
